Regenerex Pharma (RGPX) EBT Margin (2014 - 2020)
Regenerex Pharma (RGPX) reported EBT Margin of 14063.54% for Q4 2020, down 1282739.0% year-over-year from N/an in Q1 2020, and up 25.87% on a QoQ basis from 18970.83% in Q3 2020.
Regenerex Pharma (RGPX) has 3 years of EBT Margin data on file, last reported at 14063.54% in Q4 2020.
- Quarterly EBT Margin fell 1282739.0% year-over-year to 14063.54% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 6789.2% (changed N/A YoY) and the FY2020 annual result came in at 3330.98%, changed N/A from the prior year.
- EBT Margin climbed to 14063.54% in Q4 2020 per RGPX's latest filing, from 18970.83% in the prior quarter.
- Across five years, EBT Margin topped out at 1236.15% in Q4 2019 and bottomed at 25228.57% in Q2 2020.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -14,063.54% |
| Sep 30, 2020 | -18,970.83% |
| Jun 30, 2020 | -25,228.57% |
| Mar 31, 2020 | -2,308.64% |
| Dec 31, 2019 | -1,236.15% |
| Aug 31, 2014 | -644.80% |